Fasting-mimicking diet plus chemotherapy in breast cancer treatment
- 01Examine the impact of fasting-mimicking diets during chemotherapy
- 02Acknowledge that this specific trial yielded overall negative results
- 03Refine future trial designs to better evaluate nutritional interventions
- 04Investigate alternative therapeutic combinations involving fasting-mimicking diets
A fasting-mimicking diet did not show significant benefits during breast cancer chemotherapy in this specific clinical trial.
A clinical trial published in Nature Communications examined the effect of fasting-mimicking diet (FMD) during chemotherapy in breast cancer patients. The overall negative study results highlight the need for ameliorating future trial design and investigating alternative FMD-based therapeutic combinations.
- APA
- Claudio Vernieri, Francesca Ligorio, Emma Zattarin, Licia Rivoltini, & Filippo de Braud (2020). Fasting-mimicking diet plus chemotherapy in breast cancer treatment.
- MLA
- Claudio Vernieri, et al. "Fasting-mimicking diet plus chemotherapy in breast cancer treatment." 2020.
- Chicago
- Claudio Vernieri et al. 2020. "Fasting-mimicking diet plus chemotherapy in breast cancer treatment."
